Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

Rhea-AI Summary

Medline (Nasdaq: MDLN) said CEO Jim Boyle and CFO Mike Drazin will present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach on March 11, 2026 at 9:30am ET. A live webcast and a replay available for six months will be hosted on Medline's investor relations site.

News Market Reaction – MDLN

+3.36%

+3.36% Session close to close

In the Feb 18 session, MDLN gained 3.36%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Medline’s continued investor engagement through a Barclays healthcare c...

Analysis

This announcement highlights Medline’s continued investor engagement through a Barclays healthcare conference appearance on March 11, 2026, with a webcast and six-month replay. It follows prior updates on its IPO and upcoming 2025 results and fits a pattern of broadening communication with the market. Investors tracking the story may focus on execution at scheduled events, subsequent earnings disclosures, and any additional regulatory or ownership filings that refine the long-term picture.

Key Figures

Conference edition: 28th Annual Presentation date: March 11, 2026 Presentation time: 9:30am ET +1 more

4 metrics

Conference edition 28th Annual Barclays Global Healthcare Conference

Presentation date March 11, 2026 Scheduled conference presentation in Miami Beach, FL

Presentation time 9:30am ET Start time of Medline’s conference session

Webcast replay window 6 months Replay available on Medline’s investor relations website

Historical Context

3 past events · Latest: Jan 28 (Neutral)

Pattern 3 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 28	Earnings date notice	Neutral	-4.3%	Announced timing of Q4 and full-year 2025 earnings release and call.
Dec 30	Conference participation	Neutral	+0.2%	Planned presentation at J.P. Morgan Healthcare Conference with webcast access.
Dec 18	IPO and offering	Neutral	-3.7%	Closed upsized IPO and underwriters’ option exercise at $29.00 per share.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent corporate communication events (IPO, conference, earnings date notice) have seen modest single-day moves without a clear positive/negative pattern.

Recent Company History

Over the last few months, Medline has moved from its upsized IPO on Dec 18, 2025 to a series of investor-focused updates. The IPO involved a large Class A share sale at $29.00, followed by a J.P. Morgan conference participation notice and, more recently, an announcement of its upcoming Q4 and full-year 2025 results on Feb 25, 2026. Today’s Barclays conference participation fits this pattern of outreach to investors and analysts post-IPO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET.

A webcast of the presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for six months following the event.

About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Contacts
Investor Relations:
Karen King
Global Head of Investor Relations

Patrick Flaherty
Director, Investor Relations
(847) 247-7222
IR@medline.com

Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
media@medline.com

Source: Medline Inc.

FAQ

When will Medline (MDLN) present at the Barclays 28th Annual Global Healthcare Conference?

Medline will present on March 11, 2026 at 9:30am ET. According to the company, CEO Jim Boyle and CFO Mike Drazin will deliver the presentation in Miami Beach, with a live webcast available on Medline's investor relations site.

Who from Medline (MDLN) will present at the March 11, 2026 Barclays healthcare conference?

Medline's CEO Jim Boyle and CFO Mike Drazin will present at the conference. According to the company, both executives will appear on stage and the presentation will be webcast for investors via the company's IR website.

How can investors watch Medline (MDLN) present at the Barclays conference on March 11, 2026?

Investors can watch via a live webcast on Medline's investor relations Events page. According to the company, a replay will also be posted on the IR site and remain available for six months after the event.

Will Medline (MDLN) provide a replay of its Barclays conference presentation and for how long?

Yes, a replay will be available on Medline's investor relations website for six months following the event. According to the company, the replay will be posted after the live webcast for on-demand investor access.

Where is the Barclays 28th Annual Global Healthcare Conference taking place for Medline's March 11, 2026 presentation?

The conference is in Miami Beach, Florida, where Medline will present on March 11, 2026. According to the company, the session at 9:30am ET will be webcast on Medline's investor relations Events page.